| |
PRODUCT NAME |
ORDER |
 |
4-(2-PYRIDYLAZO)-N,N-DIMETHYLANILINE |
 |
 |
3-Bromo-5-Chloro-2-Picoline |
 |
 |
Boldenone Undecylenate |
 |
 |
{4-[2-(dimethylamino)ethoxy]phenyl}methanol |
 |
 |
Piperazine, 1-(2-ethoxyethyl)-4-ethyl- (9CI) |
 |
 |
Piperazine, 1-(chloroacetyl)-4-(2-methoxyethyl)- (9CI) |
 |
 |
2-Piperazineacetamide,5-methyl-3,6-dioxo-,(2S,5S)-(9CI) |
 |
 |
2-Pentanone, 4-hydroxy-4-methoxy- (9CI) |
 |
 |
1H-Benzimidazole-6-carboxylicacid,1-methyl-,methylester(9CI) |
 |
 |
1H-Benzimidazole-5-carbonyl chloride, 4,5,6,7-tetrahydro-2-methyl- (9CI) |
 |
 |
1H-Benzimidazole-5-carbonyl chloride, 4,5,6,7-tetrahydro-1-methyl- (9CI) |
 |
 |
1H-Benzimidazole-5-carbonyl chloride, 4,5,6,7-tetrahydro- (9CI) |
 |
 |
methyl 1-methyl-1H-benzo[d]imidazole-5-carboxylate |
 |
 |
2-fluoro-6-methoxynaphthalene |
 |
 |
6-methoxynaphthalen-2-amine |
 |
 |
Benzamide, 2-ethenyl-4-methyl- (9CI) |
 |
 |
Benzamide, 2-ethenyl-3-methyl- (9CI) |
 |
 |
3-Furancarboxylicacid,tetrahydro-3-hydroxy-5-oxo-,(S)-(9CI) |
 |
 |
2-ETHOXYCARBONYL-3-COUMARANONE |
 |
 |
trimethyl(thiophen-3-ylethynyl)silane |
 |
 |
16-Bromoheptadecanoic acid |
 |
 |
Acetic acid, [(4,5-dihydro-5-thioxo-1H-1,2,4-triazol-3-yl)amino]oxo- (9CI) |
 |
 |
Acetic acid, [(1,5-dihydro-5-thioxo-4H-1,2,4-triazol-4-yl)amino]oxo- (9CI) |
 |
 |
Acetic acid, oxo(1,3,4-thiadiazol-2-ylamino)- (9CI) |
 |
 |
1-(Benzoyloxy)-3-chloro-4-hydroxyquinolinium hydroxide, inner salt (6CI) |
 |
 |
2-Oxa-6-azatricyclo[4.3.1.01,3]decane (9CI) |
 |
 |
Spiro[cyclohexane-1,2-[1,5,6]triazabicyclo[3.1.0]hexane] (9CI) |
 |
 |
1,4-Diazacyclopropa[cd]pentalene(9CI) |
 |
 |
HEXAFLUOROACETONE SESQUIHYDRATE |
 |
 |
Cyclopentanecarbonyl chloride, 2-methoxy-, (1S-trans)- (9CI) |
 |
 |
Ethanone, 2,2,2-trifluoro-1-(2-phenylcyclopropyl)-, (1S-cis)- (9CI) |
 |
 |
Ethanone, 2,2,2-trifluoro-1-(2-phenylcyclopropyl)-, (1R-trans)- (9CI) |
 |
 |
a-Methyltoluene-2,a-sultam |
 |
 |
Ethanone, 1-[2-(1-hydroxy-2-methylpropyl)oxiranyl]-, (R*,S*)- (9CI) |
 |
 |
Ethanone, 1-[2-(1-hydroxypropyl)oxiranyl]-, (R*,S*)- (9CI) |
 |
 |
Ethanone, 1-[2-(1-hydroxyethyl)oxiranyl]-, (R*,S*)- (9CI) |
 |
 |
N-(4-Oxo-2-thioxo-thiazolidin-3-yl)-benzamide |
 |
 |
Diantimony trioxide |
 |
 |
(E)-N-(2-((3-(4-bromophenyl)allyl)amino)ethyl)isoquinoline-5-sulfonamide dihydrochloride |
 |
 |
Aziridine, 1-(3-pyridinylcarbonyl)- (9CI) |
 |
 |
QUININE, ANHYDROUS |
 |
 |
MAGNESIUM OXIDE, -100 MESH |
 |
 |
Pyrazino[1,2-d][1,4]diazepine-1,9(2H,6H)-dione, hexahydro- (9CI) |
 |
 |
Pyrazino[1,2-d][1,4]diazepine-1,9(2H,6H)-dione, 3,4,7,8-tetrahydro- (9CI) |
 |
 |
Benzyl N-(Diphenylmethylene)-2-acetoxyglycinate |
 |
 |
BROMOACETIC ANHYDRIDE |
 |
 |
IRON(II,III) OXIDE MAGNETOFLUID; 1.8% DISPERSED IN LIGHT MINERAL OIL |
 |
 |
IRON(III) OXIDE |
 |
 |
1H,3H-[1,3,5]Oxadiazepino[5,6-a]benzimidazole(9CI) |
 |
 |
Butanamide, N-methyl-3-oxo-N-(1-oxopropyl)- |
 |